Beryl Drugs standalone net profit declines 37.50% in the September 2016 quarter

Sales decline 25.93% to Rs 3.00 crore

Net profit of Beryl Drugs declined 37.50% to Rs 0.10 crore in the quarter ended September 2016 as against Rs 0.16 crore during the previous quarter ended September 2015. Sales declined 25.93% to Rs 3.00 crore in the quarter ended September 2016 as against Rs 4.05 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales3.004.05 -26 OPM %9.009.38 -PBDT0.220.33 -33 PBT0.120.20 -40 NP0.100.16 -38

Powered by Capital Market - Live News